Study of Tislelizumab in Combination With Chemotherapy Compared to Chemotherapy Alone for Participants With Urothelial Carcinoma | 百济神州

⟵ Back to Search Results

Study of Tislelizumab in Combination With Chemotherapy Compared to Chemotherapy Alone for Participants With Urothelial Carcinoma

Beigene Study ID

BGB-A317-310

ClinicalTrials.gov ID

NCT03967977

Clinical Drug Trials ID

CTR20190543

Study Overview

Sex: All

Age: 18 Years to 75 Years (Adult, Older Adult)

Accepts Healthy Volunteers? yes

No Study Documents

Locations

Study Overview

Sex: All

Age: 18 Years to 75 Years (Adult, Older Adult)

Accepts Healthy Volunteers? yes

No Study Documents